- Home
- HBAN vs WAT Comparison
HBAN vs WAT Comparison
Compare HBAN & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBAN
- WAT
- Stock Information
- Founded
- HBAN 1866
- WAT 1958
- Country
- HBAN United States
- WAT United States
- Employees
- HBAN N/A
- WAT N/A
- Industry
- HBAN Major Banks
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- HBAN Finance
- WAT Industrials
- Exchange
- HBAN Nasdaq
- WAT Nasdaq
- Market Cap
- HBAN 25.6B
- WAT 22.5B
- IPO Year
- HBAN N/A
- WAT 1995
- Fundamental
- Price
- HBAN $17.61
- WAT $384.05
- Analyst Decision
- HBAN Buy
- WAT Hold
- Analyst Count
- HBAN 18
- WAT 13
- Target Price
- HBAN $17.19
- WAT $363.92
- AVG Volume (30 Days)
- HBAN 12.8M
- WAT 537.5K
- Earning Date
- HBAN 01-17-2025
- WAT 02-04-2025
- Dividend Yield
- HBAN 3.52%
- WAT N/A
- EPS Growth
- HBAN N/A
- WAT N/A
- EPS
- HBAN 1.03
- WAT 10.48
- Revenue
- HBAN $6,690,000,000.00
- WAT $2,905,147,000.00
- Revenue This Year
- HBAN N/A
- WAT $0.53
- Revenue Next Year
- HBAN $5.31
- WAT $5.59
- P/E Ratio
- HBAN $17.09
- WAT $36.66
- Revenue Growth
- HBAN N/A
- WAT N/A
- 52 Week Low
- HBAN $11.78
- WAT $279.24
- 52 Week High
- HBAN $18.45
- WAT $395.50
- Technical
- Relative Strength Index (RSI)
- HBAN 58.24
- WAT 57.31
- Support Level
- HBAN $17.42
- WAT $380.14
- Resistance Level
- HBAN $17.96
- WAT $395.50
- Average True Range (ATR)
- HBAN 0.32
- WAT 10.42
- MACD
- HBAN -0.12
- WAT 0.22
- Stochastic Oscillator
- HBAN 22.94
- WAT 79.13
About HBAN Huntington Bancshares Incorporated
Huntington is a regional us bank with around $200 billion in assets (as of September 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.